WO2006064871A1 - Solid fat composition containing data-providing nucleic acid - Google Patents

Solid fat composition containing data-providing nucleic acid Download PDF

Info

Publication number
WO2006064871A1
WO2006064871A1 PCT/JP2005/023039 JP2005023039W WO2006064871A1 WO 2006064871 A1 WO2006064871 A1 WO 2006064871A1 JP 2005023039 W JP2005023039 W JP 2005023039W WO 2006064871 A1 WO2006064871 A1 WO 2006064871A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
information
solid fat
fat composition
information nucleic
Prior art date
Application number
PCT/JP2005/023039
Other languages
French (fr)
Japanese (ja)
Inventor
Hiroshi Yokoyama
Masahiko Yamanaka
Kentarou Watanabe
Tsunehiko Higuchi
Shigeki Hirabayashi
Original Assignee
Nissan Motor Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Motor Co., Ltd. filed Critical Nissan Motor Co., Ltd.
Publication of WO2006064871A1 publication Critical patent/WO2006064871A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom

Definitions

  • the present invention relates to an information nucleic acid-containing solid fat composition, and more particularly to a solid fat composition containing an information nucleic acid that can be used for individual authentication.
  • DNA is an information biomolecule originally possessed by all living organisms and including all genetic information in each organism. Many of them correspond to the amino acid sequences of many proteins. In other words, deoxyadenosine (dA), deoxyguanosine (dG), deoxycytosine (dC) and deoxythymine (dT) forces are bound with a certain direction through S-phosphate bond, and the number of bases If n is n, there are 4 n types of DNA of that length. Thus, for example, there can be about 4.3 billion distinct DNAs with only 16 bases. At present, any DNA sequence with several tens of base sequences can be synthesized arbitrarily. In addition, if the amount of DNA exceeds a certain level, the sequence can be automatically determined by an automatic sequence reader (sequencer).
  • Patent Document 1 Japanese Unexamined Patent Application Publication No. 2004-159502
  • Patent Document 1 basically relates to a method of mixing DNA and a water non-solvent, and as a method for confirming the authenticity of a product, the presence or absence of amplification of ribonucleic acid by a PCR method. By confirming the above, it is only shown that the target product containing ribonucleic acid is identified.
  • the present invention has been made in view of the above-described problems of the prior art, and the purpose of the invention is to specifically identify the source / history product.
  • An object of the present invention is to provide a solid fat composition containing an information nucleic acid.
  • the information nucleic acid-containing solid fat composition of the present invention is a solid fat composition containing an information nucleic acid having a site having an arbitrary and known base sequence.
  • the target product can be individually authenticated by determining the base arrangement 1J of the information nucleic acid contained in a trace amount.
  • solid fat means that whose viscosity exceeds lOO (mPa's) at a temperature of 30 ° C.
  • the information nucleic acid-containing solid fat composition of the present invention as described above is a solid fat composition containing an information nucleic acid having a site having an arbitrary and known base sequence.
  • an ester-based or paraffin-based one that is not particularly limited can be used.
  • ester-based oil and fat components include higher fatty acid and glycerin triesters and higher fatty acid and higher alcohol monoesters.
  • Paraffin-based fat and oil components include, for example, 16 to 40 carbon atoms, particularly carbon number. Mention may be made of 20-30 paraffins.
  • Such a solid oil composition can be used for, for example, wax, cosmetics, sarcophagus, and the like, and can contain information nucleic acids that are difficult to remove, and thus can be specifically and specifically authenticated.
  • the information nucleic acid means DNA (deoxyribonucleic acid), RNA (ribonucleic acid) and derivatives thereof, which may be natural type or artificial type, but are included in a solid oil composition that is used in harsh environments. In view of this, it is preferable to use an artificial mold that is structurally stable. In the artificial type, a sequence that does not exist in the natural type can be formed.
  • the fact that the base sequence site is arbitrary indicates that it can be selected at random as long as it is a detectable base sequence, and that the base sequence site is known is used for individual authentication. It shows that the base sequence to be used is known beforehand.
  • the content of the information nucleic acid used is preferably from 0.5 to 500 / ig, preferably from 50 to: 100, and more preferably from 100 to 100 g of the composition. ,.
  • the information nucleic acid may be detected from the solid fat composition, and the base coordination IJ may not be determined. If it exceeds 500 / g, the information nucleic acid may be identified. The impact is not good, but the cost is high.
  • the size of the information nucleic acid is preferably such that the number of bases in the whole nucleic acid is 200 or less. If it exceeds 200, unreacted sites are generated little by little at the synthesis stage, and the content of those lacking bases easily increases. More preferably, it is about 100 bases.
  • thymines are not adjacent to each other in the above base sequence. As a result, dimerization of thymine can be suppressed.
  • the information nucleic acid is derived from a protective group from the viewpoint of improving stability when used in combination with a compound that reacts with a ⁇ H group or when used in a harsh environment. It is preferable that Specifically, the hydroxyl group in one or both of the 5 and 3 groups is derivatized using a phosphate ester group, an acylol group, an alkoxycarbonyl group, a benzyl group, a substituted benzynole group and an aryl group. be able to.
  • Fig. 1 (A) shows natural DNA, and (B) shows DNA derivatized at the 5 'position.
  • the hydroxyl group at the 5 ′ position is preferable to derivatize the hydroxyl group at the 5 ′ position with piotin or a fluorescent molecule.
  • vithion when vithion is used, it is easily adsorbed selectively on a column to which a protein called avidin is bound.
  • avidin a protein called avidin is bound.
  • a fluorescent molecule such as fluorescein
  • the nucleic acid itself becomes fluorescent, so that it can be detected with high sensitivity and purification becomes easy. In this way, individual authentication becomes extremely easy if the convenience of isolation and purification is enhanced.
  • the product extracted with water can be easily separated by passing it through a column of a carrier coated with gold (Au).
  • Au gold
  • two standing hydroxyl groups can be derivatized with the above protecting groups from the viewpoint of improving stability.
  • the above base sequence site is a site used for amplification of the information nucleic acid It is preferable that As a powerful method for amplifying information nucleic acid, polymerase chain reaction (PCR) that can be amplified synergistically can be appropriately employed.
  • PCR polymerase chain reaction
  • thermostable DNA polymerase even if the amount of information nucleic acid is extremely small, it can be amplified extremely. For example, temperature control is performed in the presence of a base (primer) complementary to several tens of bases of DNA. When the thermostable DNA polymerase is allowed to act, the original DNA can be doubled. For example, if this is repeated 30 times, it can be amplified several hundred million times.
  • Such amplification makes it possible to obtain a sufficient amount of DNA to determine its sequence even from a very small amount of sample, and by extension, the “identity” of the product that contained it from the information corresponding to the sequence. Will be revealed.
  • the sites used for the amplification have primer corresponding sites necessary for polymerase chain reaction (PCR) at both ends. That is, as informational nucleic acid Although it is possible to use one that does not have a primer-corresponding site, it is possible to identify in a shorter time by providing a primer-corresponding site.
  • PCR polymerase chain reaction
  • the lower limit of the number of bases is preferably 5. More preferably, it is 10 or more. If the number of bases is less than 5, the number of distinguishable nucleic acids decreases, and it takes time to identify many products.
  • the upper limit for the number of bases is preferably 100. This is because when the number of bases exceeds 100, the ratio of by-products lacking a base at any position increases, and purification takes time and tends to be difficult in some cases.
  • RNA When RNA is used as the information nucleic acid, DNA complementary to the sequence can be obtained using reverse transcriptase, and PCR can be performed using this DNA.
  • the information nucleic acid further has an authentication information part in addition to the base sequence part, so that individual authentication can be performed by setting more detailed information.
  • an authentication information part in addition to the base sequence part, so that individual authentication can be performed by setting more detailed information.
  • FIG. 2 in the case of information DNA having primer-corresponding sites at both ends, a sequence of m bases is placed in the center (B to B), and the sequence information of this portion is used as authentication information.
  • sequences (X to X, P to P) complementary to 1 (el) and n primers are ligated, respectively.
  • the presence of this part is the first time PCR
  • the information DNA can be used as an information element as a single-stranded DNA or a double-stranded DNA complexed with a complementary sequence of DNA.
  • This primer-corresponding site IJ can be devised so that the binding of complementary sequences is as stable as possible and amplification by the PCR method proceeds smoothly.
  • each of X to X, B to B, and P to P is deoxy.
  • dA adenosine
  • dG deoxyguanosine
  • dC deoxycytosine
  • dT deoxythymine
  • the solution of the information nucleic acid extracted from the solid fat composition force, the PCR buffer solution, the sterilization Mix distilled water, at least one primer, 2,3_dioxynucleoside triphosphate (dNTP) and polymerase, (1) heat at 92-95 °° for 2-5 minutes, then ( 2a) 92-95. (2b) 20-50 for 30-60 seconds at C. 30-60 seconds at C, (2c) 70-80. In C 30 ⁇ : 120 ⁇ 50 times, after 20 ⁇ 50 times of the heat cycle, (3) 70 ⁇ 80. Heat treatment is preferably performed for 1 to 10 minutes. It is preferable to use two types of primers from the viewpoint of increasing the arbitraryness of the base sequence of the information nucleic acid.
  • dNTP 2,3_dioxynucleoside triphosphate
  • (2b) 30 seconds at 40 ° C is particularly preferred. If it is shorter than 30 seconds at 20 ° C, it will be difficult to bind the primer and DNA, and if it is longer than 60 seconds at 50 ° C, the enzyme will be deactivated. Also, in (2c), 30 seconds at 72 ° C Is particularly preferred. If it is shorter than 30 seconds at 70 ° C, the elongation becomes insufficient, and if it is longer than 120 seconds at 80 ° C, the enzyme is inactivated.
  • the repetition of the heating cycles (2a) to (2c) is because the amplification factor decreases if 30 times is less than 20 times, which is particularly preferable, and if it exceeds 50 times, time is wasted.
  • FIG. 3 shows a flow chart of an embodiment of a method for detecting the information nucleic acid contained in the information nucleic acid-containing solid fat composition.
  • S1 information DNA is extracted from the solid fat composition.
  • S2 concentrate by lyophilization.
  • S3 add two types of primers and polymerase.
  • S4 DNA is amplified by repeating PCR.
  • S5 the remaining excess primer is degraded by single-stranded DNA cleavage enzyme.
  • S6 double-stranded information DNA is purified by gel filtration.
  • S7 the sequencer determines the sequence.
  • the solid fat composition is mixed with a small amount of water, for example, when the information DNA is chemically bound when it is supported on the fine particles, Hydrolysis Etc., it can be extracted efficiently.
  • it may be concentrated using, for example, a centrifugal evaporator.
  • Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, Vent polymerase, Pfu polymerase, Bca BEST polymerase, KOD DNA polymerase, etc. can be used as the single-stranded DNA cleavage enzyme.
  • the target DNA may be amplified between S6 and S7 by repeating the same operations as in S3 and 4.
  • the sequence determination may be performed by a mass spectrometer, or may be combined with the sequence determination by a sequencer.
  • the base sequence it is desirable to compare the information nucleic acid data extracted from the product with the information nucleic acid database including at least the information nucleic acid data. This is because the time required for product certification can be significantly reduced by comparing with a database of information nucleic acids obtained in advance.
  • Examples of data stored in such a database include the electrophoresis time and the distance traveled by gel filtration (this is sufficient if the information nucleic acid itself is allowed to flow into the control lane).
  • the contained information nucleic acid is supported on fine particles.
  • “supporting” means that the information nucleic acid is in close contact with the fine particles so that they can move together with the fine particles, and the information nucleic acids are attached to the surfaces of the fine particles. Even if it is firmly fixed, it may adhere to the surface of the fine particles or in the recesses with a strength sufficient to withstand use.
  • nucleic acid Since the nucleic acid is water-soluble, it cannot be said that there is no possibility that it will flow out of the product together with water even if it is incorporated in the product.
  • the fine particles are not particularly limited as long as they can carry an information nucleic acid, but in addition to silica and zinc oxide, titanium oxide, molybdenum oxide, tungsten oxide, nor titanate and the like are suitable. Can be used. In addition, the dispersibility at the time of mixing with a solid fat composition can be improved by silica-coating the surface.
  • the content of the fine particles is 0.5 with respect to the total amount of the composition. It is preferably ⁇ 50%, more preferably 0.5 to 5%.
  • the content of fine particles is less than 0.5%, the amount of fine particles in the sampled solid fat composition may be small, and the detection accuracy may be reduced. On the other hand, if it exceeds 50%, the applicability of wax is reduced and the skin may be damaged in the case of cosmetics.
  • the average particle size is preferably 0.01 to 5 ⁇ m, more preferably 0.02 to: l x m.
  • the coating film may be damaged in the case of wax. In the case of cosmetics, there is a possibility of damaging the skin.
  • the information nucleic acid-carrying fine particles are formed by, for example, dissolving the information nucleic acid as it is in a suspension obtained by adding sterile distilled water to the fine particles, or by dissolving a part or all of the information nucleic acid in sterile distilled water. It can be obtained by adding as a solution, desirably adding a specific solvent, and drying.
  • the information nucleic acid can be reliably supported on the surface of the fine particles by drying after being held in a state, and the information nucleic acid is supported on the fine particles by using such information nucleic acid-supported fine particles.
  • the information nucleic acid can be reliably added to the solid fat composition and stably dispersed as compared with the case of introducing the information nucleic acid alone.
  • the suspension includes alcohol (eg, methanol, ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, nonanol, etc.), ester (eg, ethyl acetate, butyl acetate, Propyl acetate, etc.), ketones (eg, acetone, dimethyl ketone, methyl ethyl ketone, jetyl ketone, etc.) and aromatic solvents ( It is desirable to further add a solvent such as toluene, hexane, cyclohexane, xylene, etc. This improves the dispersibility of the fine particles in the suspension, and after the addition of the information nucleating acid. The volatilization of the water and solvent will be promoted.
  • alcohol eg, methanol, ethanol, propanol, butanol, pentanol, hexanol, hept
  • solvents are not limited to only one type, and two or more types of solvents can be used in combination. These solvents may be added at the same time as the information nucleic acid or after the information nucleic acid is added.
  • the volume ratio of sterilized distilled water Z alcohol is in the range of 1 to 99, that is, a solvent other than alcohol, that is, an ester.
  • the volume ratio of sterile distilled water Z solvent is preferably in the range of 1 to 75.
  • Informational DNA represented by SEQ ID NO: 1 (including a verifiable DNA represented by SEQ ID NO: 2) was synthesized by sequentially binding nucleosides by the phosphoramidite method.
  • an information DNA represented by SEQ ID NO: 1 was used as the information nucleic acid.
  • Zinc oxide with an average particle diameter of 0.02 xm (ZS-032 manufactured by Showa Denko KK) coated with silica was used as fine particles for the carrier, and 30% ethanol by volume ratio was added to 4 g of the zinc oxide. 15 mL of sterilized distilled water contained was added and stirred to obtain a zinc oxide suspension.
  • the fully dried lump fine powder was put in a mortar and crushed to obtain information nucleic acid-carrying fine particles as the original fine powder.
  • fine particles for the carrier zinc oxide with an average particle size of 0.02 xm (ZS _032 manufactured by Showa Denko KK) coated with silica coating, aluminum oxide with an average particle size of 5 ⁇ m coated with silica coating (Co., Ltd.) Using Micron's AX10-32) or silica-coated ano-reminium oxide with an average particle diameter of 20 ⁇ m (Micron's AX116), the content of the information nucleic acid carried on the microparticles is adjusted, or The information-nucleated acid-containing solid fat composition (wax) of this example was prepared by adjusting the content of the information-containing nucleic acid-carrying fine particles. Tables 1 and 2 show the specifications of the information nucleic acid-containing solid oil composition (wax) in each of the above examples.
  • Zinc phosphate-treated 70111111 150111111 0.8mmt dull steel plate with cationic electrodeposition paint (Nippon Paint Co., Ltd., trade name "Power Top U600M”) to have a dry film thickness of 20 zm
  • a gray paint made by NOF Corporation, trade name “HIEIPICO No. 500” was applied thereon.
  • the coating was applied to a dry film thickness of 30 xm and baked at 140 ° C for 30 minutes to form an intermediate coating layer and a base coat layer.
  • Talia paint (made by Nippon Paint Co., Ltd., trade name “Super Parrak O-130 GN3”) was applied so that the dry film thickness was 30 zm, and 3 ° C at 140 ° C.
  • a talya layer was formed by baking for 0 minutes.
  • test pieces in each of the above examples were washed with a detergent (manufactured by Taiho Kogyo Co., Ltd., Clean View) to remove the wax component, and then the degree of scratches on the coating film surface was visually confirmed.
  • a detergent manufactured by Taiho Kogyo Co., Ltd., Clean View
  • the results obtained are also shown in Tables 1 and 2. In the table, “o” indicates “no flaw” and “ ⁇ ” indicates “slightly flawed”.
  • the information nucleic acid-containing solid fat composition of the present invention can identify the information nucleic acid.
  • Example 18 has a smaller number of PCR amplifications than the information-containing nucleic acid-containing solid fat composition of Examples 13 to 17: It can be seen that the information nucleic acid can be identified.
  • the information-containing nucleic acid-containing solid fat composition of Examples 1 to 17 can form a wax coating without damaging the coating surface.
  • FIG. 1 is a structural formula showing natural DNA and DNA in which the 5 ′ position is derivatized.
  • FIG. 2 is a schematic diagram showing an information nucleic acid having primer-corresponding sites at both ends at the authentication information site.
  • FIG. 3 is a flowchart showing one embodiment of a method for detecting an information nucleic acid contained in an information nucleic acid-containing solid fat composition.

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

It is intended to provide a solid fat composition containing a data-providing nucleic acid wherein the data-providing nucleic acid contained therein enables the individual and specific determination of the origin and history of the product. This solid fat composition containing a data-providing nucleic acid contains the data-providing nucleic acid comprising a site which has an arbitrary and known base sequence. The above-described solid fat composition containing a data-providing nucleic acid contains the data-providing nucleic acid comprising a site which has an arbitrary and known base sequence and the data-providing nucleic acid is carried on fine particles. Furthermore, the above-described solid fat composition containing a data-providing nucleic acid contains the data-providing nucleic acid comprising a site which has an arbitrary and known base sequence and the content of the data-providing nucleic acid ranges from 0.5 to 500 μg per 100 g of the composition.

Description

明 細 書  Specification
情報化核酸含有固形油脂組成物  Information nucleic acid-containing solid fat composition
技術分野  Technical field
[0001] 本発明は、情報化核酸含有固形油脂組成物に係り、更に詳細には、個別認証に 利用できる情報化核酸を含有する固形油脂組成物に関する。  The present invention relates to an information nucleic acid-containing solid fat composition, and more particularly to a solid fat composition containing an information nucleic acid that can be used for individual authentication.
背景技術  Background art
[0002] 従来から、個別認証には、ナンバープレート、紙幣などの透かし印刷、 ICチップ及 びクレジットカードの写真などが利用されている。  Conventionally, for individual authentication, watermark printing of license plates, banknotes, etc., photographs of IC chips and credit cards have been used.
しかし、これらの個別認証手段は、剥離、切断、消去などにより製品から除去するこ とができるという欠点があった。このため、製品から取り除くことのできなレ、、即ち消失 しない認証情報の開発が期待されていた。  However, these individual authentication means have a drawback that they can be removed from the product by peeling, cutting, erasing and the like. For this reason, development of authentication information that cannot be removed from the product, that is, authentication information that does not disappear is expected.
[0003] 一方、 DNAは、元来全ての生物が保有し、それぞれの生物において、全ての遺伝 情報を含む情報生体分子である。その多くは多数のタンパク質のアミノ酸配列に対 応するものである。即ち、デォキシアデノシン(dA)、デォキシグアノシン(dG)、デォ キシシトシン(dC)及びデォキシチミン(dT)力 Sリン酸エステル結合を介し一定の方向 性をもって結合して成り、その塩基数を n個とすると、その長さの DNAは 4n種類存在 することになる。従って、例えばわずか 16種類の塩基数でも約 43億種類のそれぞれ 区別できる DNAが存在し得る。現在では、数十塩基配列を有する DNAであれば、 どのような配列のものでも任意に合成することができる。また、 DNAは、ある程度以上 の量があれば、 自動配列読み取り装置 (シーケンサー)で自動的にその配列を決定 すること力 Sできる。 [0003] On the other hand, DNA is an information biomolecule originally possessed by all living organisms and including all genetic information in each organism. Many of them correspond to the amino acid sequences of many proteins. In other words, deoxyadenosine (dA), deoxyguanosine (dG), deoxycytosine (dC) and deoxythymine (dT) forces are bound with a certain direction through S-phosphate bond, and the number of bases If n is n, there are 4 n types of DNA of that length. Thus, for example, there can be about 4.3 billion distinct DNAs with only 16 bases. At present, any DNA sequence with several tens of base sequences can be synthesized arbitrarily. In addition, if the amount of DNA exceeds a certain level, the sequence can be automatically determined by an automatic sequence reader (sequencer).
[0004] このような背景から、水不溶性媒体に DNAを含ませた偽造防止ラベルを製品に用 レ、ることにより、該 DNAの存在 '不存在を手掛かりにして、その製品の真偽を明らか にすることが提案されている(特許文献 1参照。)。  [0004] Against this background, by using a forgery-proof label that contains DNA in a water-insoluble medium for the product, the presence or absence of the DNA can be used as a clue to clarify the authenticity of the product. Has been proposed (see Patent Document 1).
特許文献 1:特開 2004— 159502号公報  Patent Document 1: Japanese Unexamined Patent Application Publication No. 2004-159502
発明の開示  Disclosure of the invention
発明が解決しょうとする課題 [0005] しかし、特許文献 1に記載の技術は、基本的には DNAと水不溶媒体の混合方法に 係るものであり、製品の真偽確認方法としては、 PCR法によるリボ核酸の増幅の有無 を確認することにより、リボ核酸入りの対象製品を同定することが示されているに過ぎ ない。 Problems to be solved by the invention [0005] However, the technique described in Patent Document 1 basically relates to a method of mixing DNA and a water non-solvent, and as a method for confirming the authenticity of a product, the presence or absence of amplification of ribonucleic acid by a PCR method. By confirming the above, it is only shown that the target product containing ribonucleic acid is identified.
また、 DNAの存在 '不存在を検定指標とする真偽確認データはもとより、 DNAの 配列を検定指標とし、同種製品であっても個々の製品毎の認証を可能とする、個別 認証に関するデータは開示されていない。  In addition, the data on individual certification that enables the authentication of each product even if it is the same kind of product using the DNA sequence as the test index, as well as the authenticity confirmation data using the presence / absence of DNA as the test index. Not disclosed.
[0006] 一方、 自動車事故において加害者が逃走したときなどには、事故現場に残された 塗膜片ゃガラス片、プラスチック片などから対象車両を特定したいという要請がある。 [0006] On the other hand, when a perpetrator escapes in an automobile accident, there is a demand for specifying a target vehicle from a piece of paint film, a piece of glass, a plastic piece, etc. left at the accident site.
[0007] 本発明は、このような従来技術の有する課題に鑑みてなされたものであり、その目 的とするところは、どのような出所 ·履歴の製品であるかを個別具体的に特定できる情 報化核酸を含有した固形油脂組成物を提供することにある。  [0007] The present invention has been made in view of the above-described problems of the prior art, and the purpose of the invention is to specifically identify the source / history product. An object of the present invention is to provide a solid fat composition containing an information nucleic acid.
課題を解決するための手段  Means for solving the problem
[0008] 本発明者らは、上記課題を解決すべく鋭意研究を重ねた結果、 DNAに代表される 核酸を一つの認証情報としてとらえ、製品中の情報化核酸を後から検出することなど により、上記課題が解決できることを見出し、本発明を完成するに至った。  [0008] As a result of intensive studies to solve the above problems, the inventors of the present invention regard nucleic acid typified by DNA as one piece of authentication information, and detect information nucleic acid in products later. The present inventors have found that the above problems can be solved and have completed the present invention.
[0009] 即ち、本発明の情報化核酸含有固形油脂組成物は、任意且つ既知の塩基配列を 有する部位を備える情報化核酸を含有する固形油脂組成物である。  That is, the information nucleic acid-containing solid fat composition of the present invention is a solid fat composition containing an information nucleic acid having a site having an arbitrary and known base sequence.
発明の効果  The invention's effect
[0010] 本発明によれば、工業製品などの量産品であっても、微量に含まれる情報化核酸 の塩基配歹 1Jを決定することにより、対象となる製品を個別的に認証できる。  [0010] According to the present invention, even for a mass-produced product such as an industrial product, the target product can be individually authenticated by determining the base arrangement 1J of the information nucleic acid contained in a trace amount.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0011] 以下、本発明の情報化核酸含有固形油脂組成物について詳細に説明する。なお[0011] Hereinafter, the information nucleic acid-containing solid fat composition of the present invention will be described in detail. In addition
、本明細書及び特許請求の範囲において、「%」は特記しない限り質量百分率を示 す。また、「固形油脂」とは、温度 30°Cにおいて粘度が lOO (mPa' s)を超えるものを いう。 In the present specification and claims, “%” indicates mass percentage unless otherwise specified. In addition, “solid fat” means that whose viscosity exceeds lOO (mPa's) at a temperature of 30 ° C.
[0012] 上述の如ぐ本発明の情報化核酸含有固形油脂組成物は、任意且つ既知の塩基 配列を有する部位を備える情報化核酸を含有する固形油脂組成物である。 ここで、油脂成分としては、特に限定されるものではなぐエステル系又はパラフィン 系のものを使用することができる。エステル系油脂成分としては、例えば高級脂肪酸 とグリセリンのトリエステルや高級脂肪酸と高級アルコールのモノエステルなどを挙げ ること力 Sでき、パラフィン系油脂成分としては、例えば炭素数 16〜40、特に炭素数 20 〜30のパラフィンを挙げることができる。 [0012] The information nucleic acid-containing solid fat composition of the present invention as described above is a solid fat composition containing an information nucleic acid having a site having an arbitrary and known base sequence. Here, as the oil and fat component, an ester-based or paraffin-based one that is not particularly limited can be used. Examples of ester-based oil and fat components include higher fatty acid and glycerin triesters and higher fatty acid and higher alcohol monoesters. Paraffin-based fat and oil components include, for example, 16 to 40 carbon atoms, particularly carbon number. Mention may be made of 20-30 paraffins.
このような固形油脂組成物は、例えばワックスや化粧品、石鹼等に用いることができ 、除去することが困難な情報化核酸を含有するため、個別具体的に認証することが できる。  Such a solid oil composition can be used for, for example, wax, cosmetics, sarcophagus, and the like, and can contain information nucleic acids that are difficult to remove, and thus can be specifically and specifically authenticated.
[0013] ここで、情報化核酸とは、 DNA (デォキシリボ核酸)、 RNA (リボ核酸)及びこれらの 誘導体をいい、天然型でも人工型でもよいが、使用環境が厳しい固形油脂組成物中 に含めることを考慮すると、構造的に安定している人工型を使用するのが好ましい。 人工型においては天然型には存在しない配列を形成できる。  [0013] Here, the information nucleic acid means DNA (deoxyribonucleic acid), RNA (ribonucleic acid) and derivatives thereof, which may be natural type or artificial type, but are included in a solid oil composition that is used in harsh environments. In view of this, it is preferable to use an artificial mold that is structurally stable. In the artificial type, a sequence that does not exist in the natural type can be formed.
また、情報化核酸において、塩基配列部位が任意であるとは、検出可能な塩基配 列である限り無作為に選択され得ることを示し、塩基配列部位が既知であるとは、個 別認証に用いられる塩基配列が予め把握されていることを示す。  In addition, in the information nucleic acid, the fact that the base sequence site is arbitrary indicates that it can be selected at random as long as it is a detectable base sequence, and that the base sequence site is known is used for individual authentication. It shows that the base sequence to be used is known beforehand.
[0014] 本発明において、用いられる情報化核酸の含有量は、組成物 100gに対して 0. 5 〜500 /i gであること力 S好ましく、 50〜: 100 であること力 Sより好ましレ、。  [0014] In the present invention, the content of the information nucleic acid used is preferably from 0.5 to 500 / ig, preferably from 50 to: 100, and more preferably from 100 to 100 g of the composition. ,.
0. 5 より少ない場合には、固形油脂組成物から情報化核酸を検出し、塩基配 歹 IJを決定できない可能があり、 500 / gを超える場合には、情報化核酸を識別するこ とに影響はでなレ、が、コストが高くなる。  If less than 0.5, the information nucleic acid may be detected from the solid fat composition, and the base coordination IJ may not be determined. If it exceeds 500 / g, the information nucleic acid may be identified. The impact is not good, but the cost is high.
[0015] また、本発明において、情報化核酸の大きさは、核酸全体における塩基数が 200 以下であることが好ましい。 200を超えると合成の段階でごくわずかずつ未反応部位 が生成し、塩基が欠けたものの含有量が増大し易レ、。より好ましくは 100塩基程度で あることが良い。  [0015] In the present invention, the size of the information nucleic acid is preferably such that the number of bases in the whole nucleic acid is 200 or less. If it exceeds 200, unreacted sites are generated little by little at the synthesis stage, and the content of those lacking bases easily increases. More preferably, it is about 100 bases.
更に、上記塩基配列においてチミン同士が隣接しないことが好ましい。これより、チ ミンがダイマー化するのを抑制できる。  Furthermore, it is preferable that thymines are not adjacent to each other in the above base sequence. As a result, dimerization of thymine can be suppressed.
[0016] また、本発明において、情報化核酸は、〇H基と反応する化合物と併用する場合や 厳しい環境下で使用される場合の安定性を向上させる観点から、保護基により誘導 化されていることが好ましい。具体的には、 5 立、 3 立のいずれか一方又は双方に ある水酸基を、リン酸エステル基、アシノレ基、アルコキシカルボニル基、ベンジル基、 置換べンジノレ基及びァリル基などを用いて誘導化することができる。図 1の(A)に天 然型 DNA、 (B)に 5'位を誘導化した DNAを示す。 In the present invention, the information nucleic acid is derived from a protective group from the viewpoint of improving stability when used in combination with a compound that reacts with a ◯ H group or when used in a harsh environment. It is preferable that Specifically, the hydroxyl group in one or both of the 5 and 3 groups is derivatized using a phosphate ester group, an acylol group, an alkoxycarbonyl group, a benzyl group, a substituted benzynole group and an aryl group. be able to. Fig. 1 (A) shows natural DNA, and (B) shows DNA derivatized at the 5 'position.
更に、単離や精製の利便性を高める観点から、 5'位の水酸基をピオチン又は蛍光 分子により誘導化することが好ましい。具体的には、ビチオンを用いるとアビジンとい うタンパク質を結合したカラムに選択的に吸着され易くなる。一方、フルォレセインな どの蛍光分子を用いると核酸自体が蛍光をもつようになるため、感度よく検出でき精 製等が容易になる。このように、単離や精製の利便性を高めると、個別認証が極めて 容易になる。  Furthermore, from the viewpoint of enhancing the convenience of isolation and purification, it is preferable to derivatize the hydroxyl group at the 5 ′ position with piotin or a fluorescent molecule. Specifically, when vithion is used, it is easily adsorbed selectively on a column to which a protein called avidin is bound. On the other hand, if a fluorescent molecule such as fluorescein is used, the nucleic acid itself becomes fluorescent, so that it can be detected with high sensitivity and purification becomes easy. In this way, individual authentication becomes extremely easy if the convenience of isolation and purification is enhanced.
[0017] 更にまた、例えば 5'位を硫黄に置換した場合には、水で抽出したものを更に金 (A u)をコーティングした担体のカラムを通すことで容易に分離をすることができる。 なお、情報化核酸として RNAを用いるときは、安定性を向上させる観点から 2 立の 水酸基を上記保護基により誘導化することもできる。  [0017] Furthermore, for example, when the 5'-position is substituted with sulfur, the product extracted with water can be easily separated by passing it through a column of a carrier coated with gold (Au). When RNA is used as the information nucleic acid, two standing hydroxyl groups can be derivatized with the above protecting groups from the viewpoint of improving stability.
[0018] また、情報化核酸を抽出して個別認証をする場合において、少ない含有量でも効 率良く検出されるようにする観点から、上記塩基配列部位が該情報化核酸の増幅に 用いられる部位であることが好ましい。力かる情報化核酸の増幅方法としては、相乗 的に増幅させることのできるポリメラーゼ連鎖反応(PCR)を適宜採用することができ る。  [0018] Further, in the case of performing individual authentication by extracting an information nucleic acid, from the viewpoint of efficiently detecting even a small content, the above base sequence site is a site used for amplification of the information nucleic acid It is preferable that As a powerful method for amplifying information nucleic acid, polymerase chain reaction (PCR) that can be amplified synergistically can be appropriately employed.
上記 PCR法では、情報化核酸が極微量であっても極度に増幅することができ、例 えば、 DNAの末端数十塩基と相補的な塩基(プライマー)の存在下に温度制御を行 いつつ、耐熱性の DNAポリメラーゼを作用させると、元の DNAを倍増させることがで きる。例えば、これを 30回繰り返せば、数億倍に増幅させることができる。  In the above PCR method, even if the amount of information nucleic acid is extremely small, it can be amplified extremely. For example, temperature control is performed in the presence of a base (primer) complementary to several tens of bases of DNA. When the thermostable DNA polymerase is allowed to act, the original DNA can be doubled. For example, if this is repeated 30 times, it can be amplified several hundred million times.
このような増幅によって微量のサンプルからでもその配列を決定するのに十分な量 の DNAを得ることができるようになり、延いては配列に対応する情報からそれが含ま れていた製品の「身元」が判明することになる。  Such amplification makes it possible to obtain a sufficient amount of DNA to determine its sequence even from a very small amount of sample, and by extension, the “identity” of the product that contained it from the information corresponding to the sequence. Will be revealed.
[0019] また、このとき、上記増幅に用いられる部位として、ポリメラーゼ連鎖反応(PCR)に 必要なプライマー対応部位を両端に有することが好ましい。即ち、情報化核酸として は、プライマー対応部位を備えていないものを使用することもできるが、プライマー対 応部位を備えることによってより短時間で識別できるようになることによる。 [0019] At this time, it is preferable that the sites used for the amplification have primer corresponding sites necessary for polymerase chain reaction (PCR) at both ends. That is, as informational nucleic acid Although it is possible to use one that does not have a primer-corresponding site, it is possible to identify in a shorter time by providing a primer-corresponding site.
このようなプライマー対応部位について、塩基数の下限値は 5であることが好ましい 。より好ましくは 10以上であることが良い。塩基数が 5未満では、区別できる核酸の数 が減少し、多くの製品の識別に時間力 Sかかるようになる。一方、塩基数の上限値とし ては、 100であることが好ましレ、。これは、塩基数が 100を超えると、いずれかの位置 の塩基を欠いた副生成物の比率が高くなり、精製に手間が掛かり、場合によっては 困難となる傾向があることによる。  For such a primer corresponding site, the lower limit of the number of bases is preferably 5. More preferably, it is 10 or more. If the number of bases is less than 5, the number of distinguishable nucleic acids decreases, and it takes time to identify many products. On the other hand, the upper limit for the number of bases is preferably 100. This is because when the number of bases exceeds 100, the ratio of by-products lacking a base at any position increases, and purification takes time and tends to be difficult in some cases.
なお、情報化核酸として RNAを用いるときは、逆転写酵素を用いて配列の相補的 な DNAを得、この DNAを用いて PCR法を行うことができる。  When RNA is used as the information nucleic acid, DNA complementary to the sequence can be obtained using reverse transcriptase, and PCR can be performed using this DNA.
[0020] また、上記情報化核酸としては、上記塩基配列部位の他に更に認証情報部位を有 することが好ましぐこれによつて、より詳細な情報設定により個別認証を実行できる。 例えば、図 2に示すように、両端にプライマー対応部位を備えた情報化 DNAであ れば、中央に m個の塩基数の配列を置き(B〜B )、この部分の配列情報を認証情 [0020] Further, it is preferable that the information nucleic acid further has an authentication information part in addition to the base sequence part, so that individual authentication can be performed by setting more detailed information. For example, as shown in FIG. 2, in the case of information DNA having primer-corresponding sites at both ends, a sequence of m bases is placed in the center (B to B), and the sequence information of this portion is used as authentication information.
1 m  1 m
報に対応させる。その両端には、それぞれ 1 (エル)個、 n個のプライマーに相補的な 配列(X〜X , P〜P )を連結する。この部分が存在することにより初めて PCR法の Correspond to the news. At both ends, sequences (X to X, P to P) complementary to 1 (el) and n primers are ligated, respectively. The presence of this part is the first time PCR
1 1 1 n 1 1 1 n
採用が可能となる。  Adoption is possible.
情報化 DNAはこの 1本鎖のもの又はそれと相補的な配列の DNAと複合体を形成 した 2本鎖のものを情報素子として用いることができる。このプライマー対応部位の配 歹 IJは、できるだけ相補的配列の結合が安定になり且つ PCR法による増幅が円滑に 進行するように工夫することができる。  The information DNA can be used as an information element as a single-stranded DNA or a double-stranded DNA complexed with a complementary sequence of DNA. This primer-corresponding site IJ can be devised so that the binding of complementary sequences is as stable as possible and amplification by the PCR method proceeds smoothly.
なお、図 2において、 X〜X、 B〜B、 P〜P のそれぞれは、デォキシ  In FIG. 2, each of X to X, B to B, and P to P is deoxy.
1 1 1 m 1 n  1 1 1 m 1 n
アデノシン(dA)、デォキシグアノシン(dG)、デォキシシトシン(dC)又はデォキシチ ミン (dT)及びこれらの任意の組み合わせにより構成される。  It is composed of adenosine (dA), deoxyguanosine (dG), deoxycytosine (dC) or deoxythymine (dT) and any combination thereof.
[0021] 上記 PCR法の好適例としては、固形油脂組成物に含まれる情報化核酸の塩基配 歹 IJを決定するに当たり、固形油脂組成物力 抽出された情報化核酸の溶液、 PCR緩 衝液、滅菌蒸留水、少なくとも 1種のプライマー、 2, 3 _ジデォキシヌクレオシド三リン 酸(dNTP)及びポリメラーゼを混合し、 (1) 92〜95°〇で2〜5分間加熱し、次いで、( 2a) 92〜95。Cで 30〜60秒間、(2b) 20〜50。Cで 30〜60秒間、 (2c) 70〜80。Cで 30〜: 120禾少間、のカロ熱サイクノレを 20〜50回'操り返し、し力る後、(3) 70〜80。じで1 〜10分間加熱処理することが好ましい。なお、情報化核酸の塩基配列の任意性を 高めるという観点からは 2種のプライマーを用いることが好ましい。 [0021] As a preferred example of the above PCR method, in determining the base coordination IJ of the information nucleic acid contained in the solid fat composition, the solution of the information nucleic acid extracted from the solid fat composition force, the PCR buffer solution, the sterilization Mix distilled water, at least one primer, 2,3_dioxynucleoside triphosphate (dNTP) and polymerase, (1) heat at 92-95 °° for 2-5 minutes, then ( 2a) 92-95. (2b) 20-50 for 30-60 seconds at C. 30-60 seconds at C, (2c) 70-80. In C 30 ~: 120 ~ 50 times, after 20 ~ 50 times of the heat cycle, (3) 70 ~ 80. Heat treatment is preferably performed for 1 to 10 minutes. It is preferable to use two types of primers from the viewpoint of increasing the arbitraryness of the base sequence of the information nucleic acid.
[0022] (1)において、 94°Cで 5分が特に好ましレ、。 92°Cで 2分より短いと DNAの 2本差へ の分離が困難になり、 95°Cで 5分より長いと、酵素が失活するからである。なお、製品 に含まれる情報化核酸力 S1本鎖である場合には不要である。 [0022] In (1), 5 minutes at 94 ° C is particularly preferred. If it is shorter than 2 minutes at 92 ° C, it will be difficult to separate the DNA into two strands. If it is longer than 5 minutes at 95 ° C, the enzyme will be inactivated. Note that this is not necessary when the information nucleic acid strength S1 strand contained in the product is used.
また、 (2a)において 94°Cで 30秒が特に好ましレ、。 92°Cで 30秒より短いと増幅率 が低下し、 95°Cで 60秒より長いと、酵素が失活するからである。  In (2a), 30 seconds at 94 ° C is particularly preferred. This is because the amplification factor decreases when the temperature is shorter than 30 seconds at 92 ° C, and the enzyme is deactivated when the temperature is longer than 60 seconds at 95 ° C.
更に、(2b)において 40°Cで 30秒が特に好ましレ、。 20°Cで 30秒より短いとプライマ 一と DNAの結合が困難になり、 50°Cで 60秒より長いと、酵素が失活するからである また、 (2c)において 72°Cで 30秒が特に好ましい。 70°Cで 30秒より短いと伸長が 不十分になり、 80°Cで 120秒より長いと酵素が失活するからである。  In (2b), 30 seconds at 40 ° C is particularly preferred. If it is shorter than 30 seconds at 20 ° C, it will be difficult to bind the primer and DNA, and if it is longer than 60 seconds at 50 ° C, the enzyme will be deactivated. Also, in (2c), 30 seconds at 72 ° C Is particularly preferred. If it is shorter than 30 seconds at 70 ° C, the elongation becomes insufficient, and if it is longer than 120 seconds at 80 ° C, the enzyme is inactivated.
更に、(3)において 72°Cで 7分が特に好ましい。 70°Cで 1分より短いと伸長が不十 分になり、 80°Cで 10分より長いと時間の無駄になるからである。  Further, in (3), 7 minutes at 72 ° C is particularly preferable. If it is shorter than 1 minute at 70 ° C, the elongation will be insufficient, and if it is longer than 10 minutes at 80 ° C, time will be wasted.
更にまた、加熱サイクル(2a)〜(2c)の繰り返しは、 30回が特に好ましぐ 20回より 少ないと増幅率が低下し、 50回より多いと時間の無駄になるからである。  Furthermore, the repetition of the heating cycles (2a) to (2c) is because the amplification factor decreases if 30 times is less than 20 times, which is particularly preferable, and if it exceeds 50 times, time is wasted.
[0023] 図 3に、情報化核酸含有固形油脂組成物に含まれる情報化核酸の検出方法の一 実施形態のフロー図を示す。 [0023] FIG. 3 shows a flow chart of an embodiment of a method for detecting the information nucleic acid contained in the information nucleic acid-containing solid fat composition.
同図に示すように、 S1において、固形油脂組成物から情報化 DNAを抽出する。 S 2において、凍結乾燥により濃縮する。 S3において、 2種類のプライマーとポリメラー ゼを加える。 S4において、 PCRを繰り返すことにより DNAを増幅する。 S5において 、残った余分なプライマーを一本鎖 DNA開裂酵素により分解する。 S6において、二 本鎖である情報化 DNAをゲル濾過で精製する。 S7において、シーケンサ一により 配列決定を行う。  As shown in the figure, in S1, information DNA is extracted from the solid fat composition. In S2, concentrate by lyophilization. In S3, add two types of primers and polymerase. In S4, DNA is amplified by repeating PCR. In S5, the remaining excess primer is degraded by single-stranded DNA cleavage enzyme. In S6, double-stranded information DNA is purified by gel filtration. In S7, the sequencer determines the sequence.
[0024] ここで、 S1におレ、ては、例えば固形油脂組成物を少量の水と混ぜればょレ、が、例 えば情報化 DNAを微粒子に担持させる際に化学的結合させた場合には、加水分解 などすることにより効率良く抽出することができる。また、 S2においては、例えば遠心 エバポレーターを用いて濃縮してもよレ、。更に、 S5においては、一本鎖 DNA切断酵 素として、例えば Taq DNA ポリメラーゼ、 Tth DNAポリメラーゼ、 Tfl DNAポリ メラーゼ、 Ventポリメラーゼ、 Pfuポリメラーゼ、 Bca BESTポリメラーゼ、 KOD DN Aポリメラーゼなどを使用できる。また、 S6と S7との間に、更に S3及び 4と同様の操 作を繰り返して、 目的の DNAを増幅させてもよい。 S7においては、質量分析装置に よって配列決定を行ってもよぐシーケンサーによる配列決定と組み合わせてもよい。 [0024] Here, in S1, for example, if the solid fat composition is mixed with a small amount of water, for example, when the information DNA is chemically bound when it is supported on the fine particles, Hydrolysis Etc., it can be extracted efficiently. In S2, it may be concentrated using, for example, a centrifugal evaporator. Further, in S5, for example, Taq DNA polymerase, Tth DNA polymerase, Tfl DNA polymerase, Vent polymerase, Pfu polymerase, Bca BEST polymerase, KOD DNA polymerase, etc. can be used as the single-stranded DNA cleavage enzyme. Further, the target DNA may be amplified between S6 and S7 by repeating the same operations as in S3 and 4. In S7, the sequence determination may be performed by a mass spectrometer, or may be combined with the sequence determination by a sequencer.
[0025] また、塩基配列を決定するに当たり、製品から抽出される該情報化核酸のデータと 、該情報化核酸のデータを少なくとも含む情報化核酸データベースとを対比すること が望ましい。予め把握された情報化核酸のデータベースと比較することにより製品認 証に力かる時間を大幅に減らすことが可能となるからである。 [0025] Further, in determining the base sequence, it is desirable to compare the information nucleic acid data extracted from the product with the information nucleic acid database including at least the information nucleic acid data. This is because the time required for product certification can be significantly reduced by comparing with a database of information nucleic acids obtained in advance.
かかるデータベースに蓄えられるデータとしては、例えば電気泳動時間やゲル濾過 した際の移動距離 (これは、情報化核酸自体をコントロールレーンに流せば足りる)な どを挙げること力 Sできる。  Examples of data stored in such a database include the electrophoresis time and the distance traveled by gel filtration (this is sufficient if the information nucleic acid itself is allowed to flow into the control lane).
[0026] また、本発明において、含有する情報化核酸は微粒子に担持されていることが望ま しい。  [0026] Further, in the present invention, it is desirable that the contained information nucleic acid is supported on fine particles.
ここで、本発明において「担持」とは、情報化核酸が上記微粒子の表面に乗せられ た状態で微粒子と共に移動できる程度に密着していることを意味し、情報化核酸が 上記微粒子の表面に強固に固着していても、微粒子表面やその凹部内に使用に耐 える程度の強度で付着していてもよい。  Here, in the present invention, “supporting” means that the information nucleic acid is in close contact with the fine particles so that they can move together with the fine particles, and the information nucleic acids are attached to the surfaces of the fine particles. Even if it is firmly fixed, it may adhere to the surface of the fine particles or in the recesses with a strength sufficient to withstand use.
核酸は、水溶性であることから、製品に組込んだとしても製品から水と共に流出する 可能性がないとは言えず、微粒子に担持させることによって、長期間にわたって製品 内に保持されやすくなる。  Since the nucleic acid is water-soluble, it cannot be said that there is no possibility that it will flow out of the product together with water even if it is incorporated in the product.
[0027] 上記微粒子としては、情報化核酸を担持することができれば特に限定されるもので はないが、シリカや酸化亜鉛の他、酸化チタンや酸化モリブデン、酸化タングステン、 チタン酸ノ リウムなどを好適に用いることができる。なお、表面をシリカコートすること によって、固形油脂組成物に混合した場合の分散性を向上させることができる。  [0027] The fine particles are not particularly limited as long as they can carry an information nucleic acid, but in addition to silica and zinc oxide, titanium oxide, molybdenum oxide, tungsten oxide, nor titanate and the like are suitable. Can be used. In addition, the dispersibility at the time of mixing with a solid fat composition can be improved by silica-coating the surface.
[0028] また、本発明において、当該微粒子の含有量としては、組成物全量に対して 0. 5 〜50%であることが好ましぐ 0. 5〜5%であることがより好ましい。 [0028] In the present invention, the content of the fine particles is 0.5 with respect to the total amount of the composition. It is preferably ˜50%, more preferably 0.5 to 5%.
微粒子の含有量が 0. 5%未満である場合には、サンプリングされた固形油脂組成 物中の微粒子の量が少ない場合があり、検出の精度が低下する可能性がある。また 、 50%を超える場合には、ワックスの場合は塗布性が低下し、化粧品の場合には肌 に傷を付ける可能性がある。  When the content of fine particles is less than 0.5%, the amount of fine particles in the sampled solid fat composition may be small, and the detection accuracy may be reduced. On the other hand, if it exceeds 50%, the applicability of wax is reduced and the skin may be damaged in the case of cosmetics.
[0029] 更に、当該微粒子のサイズとしては、平均粒径が 0. 01〜5 μ mであることが好まし く、 0. 02〜: l x mであることがより好ましい。 [0029] Further, as the size of the fine particles, the average particle size is preferably 0.01 to 5 µm, more preferably 0.02 to: l x m.
微粒子の平均粒径が 0. 01 x m未満である場合には、情報化核酸の識別精度が 低下し、 5 z mを超える場合には、ワックスの場合は、塗膜に傷が付く可能性があり、 化粧品の場合は肌に傷をつける可能性がある。  If the average particle size of the fine particles is less than 0.01 xm, the identification accuracy of the information nucleic acid will decrease. If it exceeds 5 zm, the coating film may be damaged in the case of wax. In the case of cosmetics, there is a possibility of damaging the skin.
[0030] かかる情報化核酸担持微粒子は、例えば微粒子に滅菌蒸留水を加えて成る懸濁 液に、情報化核酸をそのまま、あるいは情報化核酸の一部又は全部を滅菌蒸留水 に溶解して成る溶液として加え、望ましくはさらに特定の溶媒を添加して、乾燥させる ことによって得ることができる。 The information nucleic acid-carrying fine particles are formed by, for example, dissolving the information nucleic acid as it is in a suspension obtained by adding sterile distilled water to the fine particles, or by dissolving a part or all of the information nucleic acid in sterile distilled water. It can be obtained by adding as a solution, desirably adding a specific solvent, and drying.
シリカや亜鉛華などの微粒子の懸濁液に、任意且つ既知の塩基配列を有する部位 を備えた情報化核酸を直接、あるいは情報化核酸の一部又は全部を滅菌蒸留水に 溶解させた溶液の状態でカ卩えたのち、乾燥させることによって、微粒子の表面に情報 化核酸を確実に担持することができ、このような情報化核酸担持微粒子を用いて、情 報化核酸を微粒子に担持させた状態で固形油脂組成物中に導入することによって、 情報化核酸単独の状態で導入した場合に較べて、情報化核酸を固形油脂組成物中 に確実に添加し、安定に分散させることができるようになり、し力も情報化核酸の水分 による流出を防止することができ、情報化核酸の塩基配列を検出指標とする製品の 出所 ·経歴の個別認証が長期にわたって可能なものになるという極めて優れた効果 力あたらされる。  An information nucleic acid with a site having an arbitrary and known base sequence directly in a suspension of fine particles such as silica and zinc oxide, or a solution of a part or all of the information nucleic acid dissolved in sterile distilled water The information nucleic acid can be reliably supported on the surface of the fine particles by drying after being held in a state, and the information nucleic acid is supported on the fine particles by using such information nucleic acid-supported fine particles. By introducing into the solid fat composition in a state, the information nucleic acid can be reliably added to the solid fat composition and stably dispersed as compared with the case of introducing the information nucleic acid alone. The ability to prevent the outflow of information nucleic acid due to moisture can be prevented, and it is extremely possible that individual verification of the source and history of products using the base sequence of information nucleic acid as a detection index will be possible over a long period of time. It is hit the effect force.
[0031] また、懸濁液には、アルコール(例えば、メタノーノレ、エタノール、プロパノール、ブ タノ一ノレ、ペンタノール、へキサノール、ヘプタノール、ォクタノール、ノナノールなど) 、エステル(例えば、酢酸ェチル、酢酸ブチル、酢酸プロピルなど)、ケトン(例えば、 アセトン、ジメチルケトン、メチルェチルケトン、ジェチルケトンなど)及び芳香族溶剤( トルエン、へキサン、シクロへキサン、キシレンなど)の溶媒をさらに添加することが望 ましぐこれによつて微粒子の懸濁液中における分散性が向上すると共に、情報化核 酸が添加された後の水分及び溶剤分の揮発が促進されることになる。 [0031] In addition, the suspension includes alcohol (eg, methanol, ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, nonanol, etc.), ester (eg, ethyl acetate, butyl acetate, Propyl acetate, etc.), ketones (eg, acetone, dimethyl ketone, methyl ethyl ketone, jetyl ketone, etc.) and aromatic solvents ( It is desirable to further add a solvent such as toluene, hexane, cyclohexane, xylene, etc. This improves the dispersibility of the fine particles in the suspension, and after the addition of the information nucleating acid. The volatilization of the water and solvent will be promoted.
なお、これら溶媒は 1種のみに限定されず、 2種以上の溶媒を併用することも可能 である。また、これら溶媒は、情報化核酸と同時、あるいは情報化核酸を加えた後に 添加しても、特に差し支えはない。  These solvents are not limited to only one type, and two or more types of solvents can be used in combination. These solvents may be added at the same time as the information nucleic acid or after the information nucleic acid is added.
[0032] 更に、溶媒の添カ卩量としては、アルコールの場合には、滅菌蒸留水 Zアルコール の容量比を 1〜99の範囲とすることが好ましぐアルコール以外の溶媒の場合、即ち エステル、ケトン、芳香族溶剤の場合には、滅菌蒸留水 Z溶媒の容量比を 1〜75の 範囲とすることが好ましい。 [0032] Further, as the amount of solvent added, in the case of alcohol, it is preferable that the volume ratio of sterilized distilled water Z alcohol is in the range of 1 to 99, that is, a solvent other than alcohol, that is, an ester. In the case of a ketone or an aromatic solvent, the volume ratio of sterile distilled water Z solvent is preferably in the range of 1 to 75.
即ち、溶媒の添加量が少な過ぎると、溶媒添加による上記効果が十分に得られず、 逆に多過ぎても、水との相溶性低下によって水が揮発せずに残り易くなり、上記効果 が十分に得られないようになる傾向がある。  That is, if the addition amount of the solvent is too small, the above effect due to the addition of the solvent cannot be sufficiently obtained. Conversely, if the addition amount is too large, the water tends to remain without volatilization due to a decrease in compatibility with water. There is a tendency to become insufficient.
実施例  Example
[0033] 以下、本発明をレ、くつかの実施例により更に詳細に説明するが、本発明はこれら実 施例に限定されるものではない。  Hereinafter, the present invention will be described in more detail with reference to several examples, but the present invention is not limited to these examples.
[0034] (実施例 1) [Example 1]
[情報化核酸担持微粒子の作製]  [Preparation of information nucleic acid-supported fine particles]
配列番号 1で表される情報化 DNA (配列番号 2で表される可認証 DNAを含む)を 、ホスホアミダイト法にてヌクレオシドを逐次結合させることによって合成した。  Informational DNA represented by SEQ ID NO: 1 (including a verifiable DNA represented by SEQ ID NO: 2) was synthesized by sequentially binding nucleosides by the phosphoramidite method.
以下、実施例 1〜20において、情報化核酸としては、配列番号 1で表される情報化 DNAを用いた。  Hereinafter, in Examples 1 to 20, an information DNA represented by SEQ ID NO: 1 was used as the information nucleic acid.
担体用の微粒子として、シリカコートを施した平均粒径 0. 02 x mの酸化亜鉛(昭和 電工 (株)製 ZS— 032)を使用し、当該酸化亜鉛 4gに、容量比で 30%のエタノール を含有する滅菌蒸留水 15mLを加えて撹拌し、酸化亜鉛の懸濁液を得た。  Zinc oxide with an average particle diameter of 0.02 xm (ZS-032 manufactured by Showa Denko KK) coated with silica was used as fine particles for the carrier, and 30% ethanol by volume ratio was added to 4 g of the zinc oxide. 15 mL of sterilized distilled water contained was added and stirred to obtain a zinc oxide suspension.
情報化DNA10nmol (164 μ g)を滅菌蒸留水15mLに溶解し、得られた情報化 D NA水溶液を懸濁液に加えて良く撹拌し、さらに 4mLのエタノールをカ卩えて撹拌した 情報化 DNAをカ卩えた懸濁液をプラスチック製の円形皿に注ぎ、その上部を通気性 の良い紙あるいは布で覆った状態で、 2日間自然乾燥した。更に、ほぼ乾燥したもの をデシケータに入れ、 40°Cの加熱下で減圧乾燥し、十分に乾燥させた。 10 nmol (164 μg) of informational DNA was dissolved in 15 mL of sterile distilled water, and the resulting informational aqueous DNA solution was added to the suspension and stirred well. Further, 4 mL of ethanol was added and stirred. The suspension containing the computerized DNA was poured into a plastic circular dish and air-dried for two days with the top covered with air-permeable paper or cloth. Further, the almost dried product was put in a desiccator and dried under reduced pressure under heating at 40 ° C. to be sufficiently dried.
十分に乾燥された塊状の微粉末を乳鉢に入れて砕き、もとの微粉末状として、情報 化核酸担持微粒子を得た。  The fully dried lump fine powder was put in a mortar and crushed to obtain information nucleic acid-carrying fine particles as the original fine powder.
[0035] [情報化核酸含有固形油脂組成物の作製] [0035] [Preparation of computerized nucleic acid-containing solid fat composition]
50gの情報化核酸担持微粒子と軟化させた lOOOgのワックス(タイホー工業製、ス 一パーイオンコート)を混合して、本例の情報化核酸含有固形油脂組成物(ワックス) を作製した。  50 g of information nucleic acid-carrying fine particles and softened lOOOOg wax (made by Taiho Kogyo Co., Ltd., Super Ion Coat) were mixed to prepare an information nucleic acid-containing solid fat composition (wax) of this example.
[0036] (実施例 2〜: 18) [0036] (Examples 2 to 18)
担体用の微粒子として、シリカコートを施した平均粒径 0. 02 x mの酸化亜鉛(昭和 電工 (株)製 ZS _032)、シリカコートを施した平均粒径 5 μ mの酸化アルミニウム(( 株)マイクロン製 AX10— 32)若しくはシリカコートを施した平均粒径 20 μ mの酸化ァ ノレミニゥム((株)マイクロン製 AX116)を用いて、微粒子に担持する情報化核酸の含 有量を調整し、又は情報化核酸担持微粒子の含有量を調整して、本例の情報化核 酸含有固形油脂組成物 (ワックス)を作製した。上記各例の情報化核酸含有固形油 脂組成物(ワックス)の仕様を表 1及び表 2に示す。  As fine particles for the carrier, zinc oxide with an average particle size of 0.02 xm (ZS _032 manufactured by Showa Denko KK) coated with silica coating, aluminum oxide with an average particle size of 5 μm coated with silica coating (Co., Ltd.) Using Micron's AX10-32) or silica-coated ano-reminium oxide with an average particle diameter of 20 μm (Micron's AX116), the content of the information nucleic acid carried on the microparticles is adjusted, or The information-nucleated acid-containing solid fat composition (wax) of this example was prepared by adjusting the content of the information-containing nucleic acid-carrying fine particles. Tables 1 and 2 show the specifications of the information nucleic acid-containing solid oil composition (wax) in each of the above examples.
[0037] [表 1] [0037] [Table 1]
Figure imgf000011_0002
Figure imgf000011_0002
[0038] [表 2] [0038] [Table 2]
Figure imgf000011_0001
[0039] [評価試験]
Figure imgf000011_0001
[0039] [Evaluation test]
(試験片の作製)  (Preparation of test piece)
(1)リン酸亜鉛処理した70111111 150111111し 0. 8mmtのダル鋼板に、カチオン 型電着塗料(日本ペイント (株)製、商品名「パワートップ U600M」)を乾燥膜厚が 20 z mとなるように電着塗装した後、 160°Cで 30分間焼付けて、下塗り層を形成し、次 いで、この上に、グレーの塗料(日本油脂(株)製、商品名「ハイエピコ No. 500」)を 乾燥膜厚が 30 x mとなるように塗装し、 140°Cで 30分間焼付けることによって、中塗 り層を形成し、ベースコート層を形成した。  (1) Zinc phosphate-treated 70111111 150111111 0.8mmt dull steel plate with cationic electrodeposition paint (Nippon Paint Co., Ltd., trade name "Power Top U600M") to have a dry film thickness of 20 zm After the electrodeposition coating, it was baked at 160 ° C for 30 minutes to form an undercoat layer, and then a gray paint (made by NOF Corporation, trade name “HIEIPICO No. 500”) was applied thereon. The coating was applied to a dry film thickness of 30 xm and baked at 140 ° C for 30 minutes to form an intermediate coating layer and a base coat layer.
そして、このベースコート層の上に、タリヤー塗料(日本ペイント(株)製、商品名「ス 一パーラック O— 130 GN3」)を乾燥膜厚が 30 z mとなるように塗装し、 140°Cで 3 0分間焼付けることによってタリヤー層を形成した。  Then, on this base coat layer, Talia paint (made by Nippon Paint Co., Ltd., trade name “Super Parrak O-130 GN3”) was applied so that the dry film thickness was 30 zm, and 3 ° C at 140 ° C. A talya layer was formed by baking for 0 minutes.
(2)塗膜表面に、上記各例の情報化核酸含有固形油脂組成物 (ワックス)を掛けて膜 厚が 100 μ mのワックス被膜を形成して試験片を作製した。  (2) The information nucleic acid-containing solid fat composition (wax) of each of the above examples was applied to the surface of the coating film to form a wax film with a film thickness of 100 μm to prepare a test piece.
[0040] (情報化核酸の識別)  [0040] (Identification of information nucleic acid)
(1)上記各例の試験片から削剥した情報化核酸含有固形油脂組成物 (ワックス)に 滅菌蒸留水 5mLを加え、マグネチックスターラーにより攪拌して、 DNAを水層に抽 出しに。  (1) Add 5 mL of sterilized distilled water to the solidified oil / fat composition containing information nucleic acid (wax) scraped from the test piece of each of the above examples, and stir with a magnetic stirrer to extract the DNA into the aqueous layer.
(2)遠心分離機を用いて、ワックスと水層を分離し、水層を遠心エバポレータを用い て濃縮した。  (2) The wax and the aqueous layer were separated using a centrifuge, and the aqueous layer was concentrated using a centrifugal evaporator.
(3)溶出回収した DNA溶液(5 μ L)に、 PCR buffer (5 μ L)、 Taq  (3) Add the eluted and recovered DNA solution (5 μL) to the PCR buffer (5 μL), Taq
polymerase (0. 25 /i L)、滅菌蒸留水(24· 75 μ L)、配列番号 3で表される 5 β polymerase (0. 25 / i L), sterile distilled water (24 · 75 μL), 5 β represented by SEQ ID NO: 3
Μのプライマー 1 (5 μ L)、配列番号 4で表される 5 μ Μのプライマー 2 (5 μ L)、及び 2mMの dNTP (5 μ L)を混合した。 Amber primer 1 (5 μL), 5 μΜ primer 2 (5 μL) represented by SEQ ID NO: 4 and 2 mM dNTP (5 μL) were mixed.
(4) 94°Cで 5分間加熱後、 [94°Cで 30秒間加熱→40°Cで 30秒間加熱→72°Cで 30 秒間加熱]のサイクルを 30回繰り返した。  (4) After heating at 94 ° C for 5 minutes, the cycle of [heating at 94 ° C for 30 seconds → heating at 40 ° C for 30 seconds → heating at 72 ° C for 30 seconds] was repeated 30 times.
(5) 72°Cで 7分間加熱処理した後、 4°Cで保存した。  (5) After heat treatment at 72 ° C for 7 minutes, it was stored at 4 ° C.
(6) 1本鎖 DNA開裂酵素(S1ヌクレアーゼ(一本鎖 DNAに特異的に反応))を用い て、余分なプライマーを分解し、 目的の 2本鎖情報化 DNAをゲル濾過で精製した。 (7)精製した情報化 DNAに 1種類のプライマー(配列番号 3で表されるプライマー 1) 及び蛍光標識した 2, 3—ジデォキシヌクレオシド三リン酸を混合した。 (6) Using a single-stranded DNA cleaving enzyme (S1 nuclease (reacts specifically with single-stranded DNA)), the excess primer was decomposed and the target double-stranded information DNA was purified by gel filtration. (7) One kind of primer (primer 1 represented by SEQ ID NO: 3) and fluorescently labeled 2,3-dideoxynucleoside triphosphate were mixed with purified information DNA.
(8)上記工程 (3)〜(5)と同様の操作を行った。  (8) The same operations as in the above steps (3) to (5) were performed.
(9)ゲル濾過精製後、 自動シーケンサーに供し、配列決定を行った。  (9) After gel filtration purification, it was subjected to sequencing using an automatic sequencer.
[0041] 得られた結果を表 1及び表 2に併記する。表中「情報化 DNAの識別」において、「 〇」は上記情報化核酸の検出方法により識別することが可能であったもの、「△」は P CR処理の回数を増やした以外は、上記情報化核酸の検出方法と同様の操作により 識別することが可能であったものを示す。  [0041] The results obtained are also shown in Tables 1 and 2. In “Identification of information DNA” in the table, “◯” indicates that the information nucleic acid was detected by the above detection method, and “△” indicates the above information except that the number of times of PCR treatment was increased. This indicates those that could be identified by the same operation as the method for detecting activated nucleic acids.
[0042] (傷付き性評価)  [0042] (Scratch evaluation)
上記各例の試験片を、洗剤(タイホー工業製、クリーンビュー)で洗浄して、ワックス 分を除去した後、塗膜表面の傷付き程度を目視で確認した。得られた結果を表 1及 び表 2に併記する。なお、表中「傷付き性」において「〇」は「傷がない」、「△」は「若 干の傷がある」を示す。  The test pieces in each of the above examples were washed with a detergent (manufactured by Taiho Kogyo Co., Ltd., Clean View) to remove the wax component, and then the degree of scratches on the coating film surface was visually confirmed. The results obtained are also shown in Tables 1 and 2. In the table, “o” indicates “no flaw” and “△” indicates “slightly flawed”.
[0043] 表 1及び表 2より、本発明の情報化核酸含有固形油脂組成物は、情報化核酸の識 別をすることができることが分かる。  [0043] From Table 1 and Table 2, it can be seen that the information nucleic acid-containing solid fat composition of the present invention can identify the information nucleic acid.
また、実施例:!〜 12及び実施例 18の情報化核酸含有固形油脂組成物は、実施例 13〜: 17の情報化核酸含有固形油脂組成物と比較して、より少ない PCRの増幅回数 で情報化核酸の識別をすることができることが分かる。  In addition, the information-containing nucleic acid-containing solid fat composition of Examples:! To 12 and Example 18 has a smaller number of PCR amplifications than the information-containing nucleic acid-containing solid fat composition of Examples 13 to 17: It can be seen that the information nucleic acid can be identified.
更に、実施例 1〜: 17の情報化核酸含有固形油脂組成物は、塗膜表面を傷付ける ことなくワックス被膜を形成することができる。  Furthermore, the information-containing nucleic acid-containing solid fat composition of Examples 1 to 17 can form a wax coating without damaging the coating surface.
図面の簡単な説明  Brief Description of Drawings
[0044] [図 1]天然 DNAとこの 5'位を誘導化した DNAを示す構造式である。  [0044] FIG. 1 is a structural formula showing natural DNA and DNA in which the 5 ′ position is derivatized.
[図 2]認証情報部位に両端にプライマー対応部位を有する情報化核酸を示す概略 図である。  FIG. 2 is a schematic diagram showing an information nucleic acid having primer-corresponding sites at both ends at the authentication information site.
[図 3]情報化核酸含有固形油脂組成物に含まれる情報化核酸の検出方法の一実施 形態を示すフロー図である。  FIG. 3 is a flowchart showing one embodiment of a method for detecting an information nucleic acid contained in an information nucleic acid-containing solid fat composition.

Claims

請求の範囲 The scope of the claims
[1] 任意かつ既知の塩基配列を有する部位を備えた情報化核酸を含有することを特徴 とする情報化核酸含有固形油脂組成物。  [1] An information nucleic acid-containing solid fat composition comprising an information nucleic acid having a site having an arbitrary and known base sequence.
[2] 上記情報化核酸の含有量が、組成物 100gに対して 0. 5-500 μ gであることを特 徴とする請求項 1に記載の情報化核酸含有固形油脂組成物。  [2] The information nucleic acid-containing solid fat composition according to claim 1, wherein the content of the information nucleic acid is 0.5 to 500 μg with respect to 100 g of the composition.
[3] 上記油脂成分がエステル系又はパラフィン系であることを特徴とする請求項 1又は[3] The oil or fat component is ester-based or paraffin-based, or
2に記載の情報化核酸含有固形油脂組成物。 2. The information nucleic acid-containing solid fat composition according to 2.
[4] 上記情報化核酸が微粒子に担持されていることを特徴とする請求項 1〜3のいずれ 力 1つの項に記載の情報化核酸含有固形油脂組成物。 [4] The information nucleic acid-containing solid fat composition according to any one of claims 1 to 3, wherein the information nucleic acid is supported on fine particles.
[5] 上記微粒子の平均粒径が、 0. 01〜5 μ mであることを特徴とする請求項 4に記載 の情報化核酸含有固形油脂組成物。 [5] The information nucleic acid-containing solid fat composition according to claim 4, wherein the fine particles have an average particle size of 0.01 to 5 μm.
[6] 上記微粒子の含有量が、組成物全量に対して 0. 5〜50%であることを特徴とする 請求項 4又は 5に記載の情報化核酸含有固形油脂組成物。 6. The information nucleic acid-containing solid fat composition according to claim 4 or 5, wherein the content of the fine particles is 0.5 to 50% with respect to the total amount of the composition.
[7] ワックス、化粧品及び石鹼から成る群より選ばれた少なくとも 1種のものに用いられ ることを特徴とする請求項:!〜 6のいずれか 1つの項に記載の情報化核酸含有固形 油脂組成物。 [7] The information nucleic acid-containing solid according to any one of [6] to [6], which is used for at least one selected from the group consisting of waxes, cosmetics, and stone walls Oil composition.
PCT/JP2005/023039 2004-12-15 2005-12-15 Solid fat composition containing data-providing nucleic acid WO2006064871A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-362147 2004-12-15
JP2004362147A JP2006169338A (en) 2004-12-15 2004-12-15 Informational nucleic acid-containing solid fat composition

Publications (1)

Publication Number Publication Date
WO2006064871A1 true WO2006064871A1 (en) 2006-06-22

Family

ID=36587925

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/023039 WO2006064871A1 (en) 2004-12-15 2005-12-15 Solid fat composition containing data-providing nucleic acid

Country Status (2)

Country Link
JP (1) JP2006169338A (en)
WO (1) WO2006064871A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707790D0 (en) * 2007-04-23 2007-05-30 Oxford Ancestors Ltd Nucleic acid-containing media

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503242A (en) * 1986-04-09 1988-11-24 バイオタル・リミテツド A sign for an item whose authenticity you want to prove
WO2004035831A1 (en) * 2002-10-16 2004-04-29 Bioneer Corporation Method for identifying vehicle and oligonucleotide marker used therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503242A (en) * 1986-04-09 1988-11-24 バイオタル・リミテツド A sign for an item whose authenticity you want to prove
WO2004035831A1 (en) * 2002-10-16 2004-04-29 Bioneer Corporation Method for identifying vehicle and oligonucleotide marker used therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAHLER ET AL: "DNA-labeled clay: A sensitive new method for tracing particle transport", GEOLOGY, vol. 26, no. 9, 1998, pages 831 - 834, XP002996483 *

Also Published As

Publication number Publication date
JP2006169338A (en) 2006-06-29

Similar Documents

Publication Publication Date Title
CN105164279B (en) Multiplex analysis of target nucleic acids
US8497067B2 (en) Restoration of nucleic acid from degraded or formalin-fixed and paraffin-embedded tissue and uses thereof
US20090036664A1 (en) Complex oligonucleotide primer mix
US20110039304A1 (en) Methods to Generate Oligonucleotide Pools and Enrich Target Nucleic Acid Sequences
WO1999036571A2 (en) Method for the detection or nucleic acid of nucleic acid sequences
JP2006122042A (en) Method for product certification
US20060088861A1 (en) Information nucleic acid-carrying fine particles and production method thereof
JP2017537657A (en) Target sequence enrichment
WO2006064871A1 (en) Solid fat composition containing data-providing nucleic acid
US20060084100A1 (en) Information nucleic acid and information nucleic acid composition using the same
WO2013123440A1 (en) Rnase h-based rna profiling
KR20190137718A (en) Method for Detecting Target Nucleic Acid Using Rolling Circle Amplification and Composition for Detecting Target Nucleic Acid
WO2006064870A1 (en) Fluid fat composition containing data-providing nucleic acid
JP2006169341A (en) Ink composition containing information nucleic acid
US20050009047A1 (en) Global linear non-biased nucleic acid amplification
JP4674796B2 (en) Non-exposed surface coating composition and non-exposed surface coating
JP4674794B2 (en) Clear coating composition and clear coating film
JP4674795B2 (en) Matte paint composition and matte paint film
JP4674793B2 (en) Undercoat paint composition and undercoat coating film
JP2006169342A (en) Adhesive
EP2173909A1 (en) Target preparation for parallel sequencing of complex genomes
JP2006167558A (en) Repair coating film and repair coating method
JP2006172025A (en) Laminated coated film structure
JP2006169332A (en) Colored topcoat coating composition and colored topcoat coating film
JP2006168084A (en) Laminated coating film structure

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05816873

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 5816873

Country of ref document: EP